Skip to content
SUROS RxPlus

Individual Treatments

GHK-Cu

Injectable formulation

GHK-Cu illustrative vial mockup

Illustrative packaging. Actual packaging may vary.

A licensed provider reviews your health history and determines whether this treatment is appropriate.

Get started

Prescription when appropriate.

Review treatment-specific information with your provider.

Commonly reported effects may include injection-site irritation, redness, swelling, or burning/stinging and allergic-type reactions are possible. See full safety information ↓

Overview

A provider-reviewed treatment option.

GHK-Cu is a prescription formulation for patients focused on skin, hair, and visible aging. A licensed provider reviews your health history and determines whether treatment is appropriate for you.

Your care journey

A simple, supportive process.

  1. 1

    Complete an online assessment

    Share some basic information about your health and goals.

  2. 2

    Provider review

    A licensed provider reviews your health history and determines whether treatment is appropriate.

  3. 3

    Ongoing care

    If prescribed, you'll have continued support from our care team.

Common questions about GHK-Cu

Who is a candidate for GHK-Cu?

A licensed provider reviews your health history and goals. If you meet medical criteria, your provider may prescribe GHK-Cu as part of your plan.

How is GHK-Cu administered?

As prescribed, typically by injection according to your provider's instructions.

Is injectable GHK-Cu FDA-approved?

GHK-Cu is FDA-approved only for topical cosmetic use; the injectable form is compounded and not itself FDA-approved. See Important Safety Information for details.

Related treatments

Molecular profile

Formula
C₁₄H₂₄N₆O₄ (GHK tripeptide)
Molecular weight
340.38 g/mol
CAS number
49557-75-7 (GHK); 89030-95-5 (copper-complex form)
Sequence
Gly-His-Lys

Important Safety Information

Compounded GHK-Cu is not FDA-approved. Its safety and effectiveness have not been established through large-scale human clinical trials of the compounded formulation, and product strength and quality may vary by compounding pharmacy. Use during pregnancy or breastfeeding, or in patients managing a serious or active medical condition, should be discussed with a provider first.

Reported effects (from available research and clinical reports — not an FDA-established safety profile):

  • Injection-site irritation, redness, swelling, or burning/stinging
  • Allergic-type reactions are possible

GHK-Cu is FDA-approved only for topical cosmetic use. Safety data for the injectable form is substantially more limited.

Always use GHK-Cu exactly as prescribed, and discuss any questions or side effects with your healthcare provider.